Induction neoadjuvant gimeracil/oteracil/tegafur + S-1 then radiotherapy + gimeracil/oteracil/tegafur + S-1 vs radiotherapy + gimeracil/oteracil/tegafur + S-1 alone in patients with oesophageal cancer

Trial Profile

Induction neoadjuvant gimeracil/oteracil/tegafur + S-1 then radiotherapy + gimeracil/oteracil/tegafur + S-1 vs radiotherapy + gimeracil/oteracil/tegafur + S-1 alone in patients with oesophageal cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Mar 2015

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary) ; Oxaliplatin
  • Indications Oesophageal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Jun 2012 New trial record
    • 05 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top